Follow-up strategies after curative resection of colorectal cancer (Q35180559)

7 August 2017

1 reference

title

Follow-up strategies after curative resection of colorectal cancer (English)

1 reference

7 August 2017

1 reference

1 reference

1

Jeffrey A Meyerhardt

1 reference

7 August 2017

Robert J Mayer

2

1 reference

7 August 2017

publication date

1 June 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

30

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

349-360

1 reference

7 August 2017

cites work

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Diagnosing colorectal carcinoma: clinical and molecular approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Surgical treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Surgical treatment of liver metastases in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Liver resection for colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Colorectal lung metastases: results of surgical excision

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

The pattern of recurrent colorectal cancer in a prospective randomised study and the characteristics of diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Value of outpatient follow-up after curative surgery for carcinoma of the large bowel.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Follow-Up of Patients with Colorectal Cancer A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Plasma CEA in the post-surgical monitoring of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Value of carcinoembryonic antigen in the management of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Serum CEA testing in the post-operative surveillance of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Comparing predictive decision rules in postoperative CEA monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Colorectal cancer. The bases for a comprehensive follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Resected pulmonary metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

The value of intensive follow-up after curative resection for colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Colonoscopic surveillance after curative resection for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Surveillance of colorectal cancer: effectiveness of early detection of intraluminal recurrences on prognosis and survival of patients treated for cure

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Late development of metachronous colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Cumulative incidence of metachronous colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Outcome after multiple colorectal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

The lesion of the second cancer of the large bowel

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Colorectal cancer: metachronous and other associated neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Multiple colorectal tumors. An appraisal of natural history and therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Results of treatment of colorectal cancer at the Peter Bent Brigham Hospital from 1960 to 1965

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

The significance of multiple adenocarcinomas of the colon and rectum

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Six-year results of annual colonoscopy after resection of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Routine colonoscopy in the management of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Colonoscopic follow-up of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

The value of colonoscopic surveillance after curative resection for colorectal cancer or synchronous adenomatous polyps

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

A prospective randomized study of follow-up after radical surgery for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Follow-up of patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Cost of patient follow-up after potentially curative colorectal cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Follow-up in colorectal cancer patients: a cost-benefit analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Detection of recurrence after surgery for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

How tumor stage affects surgeons' surveillance strategies after colon cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Geographic variation in patient surveillance after colon cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

How practice patterns in colon cancer patient follow-up are affected by surgeon age

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Surveillance after curative colon cancer resection: practice patterns of surgical subspecialists.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

Heterogeneity of cancer surveillance practices among medical oncologists in Washington and Oregon

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900095-2

7 January 2021

10.1016/S0093-7754(03)00095-2

Identifiers

DOI

1 reference

7 August 2017

1 reference